We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.565 | 1.53 | 1.60 | 1.60 | 1.536 | 1.60 | 3,320,751 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.43 | 17.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/1/2023 09:02 | Go and do some research - starting by contacting those close to the coal face! | the chairman elect | |
09/1/2023 08:59 | No current requirement but the market whispers are that they will soon get a large capital injection as part of a JV with a USA Industry giant! | the chairman elect | |
09/1/2023 08:52 | When was the last funding | nasnas1 | |
09/1/2023 08:40 | With 980mio shares already in issue, I reckon MadVlad is going to try to get funding away at at 2- 2.25 PPS. Perhaps he'll try for 7.5-10 Mio...which would dilute existing shareholders by up to 50%. | badger60 | |
09/1/2023 08:34 | Just massive , MM do not know how to play it , let it go straight up to 4 for starters! | jotoha2 | |
09/1/2023 08:30 | Going much higher some say 10p+ | the chairman elect | |
09/1/2023 08:20 | No 1 on the leaders board @ 8.20 a.m. | the chairman elect | |
09/1/2023 08:19 | Def a fundraising pump. | luckyabbeygale | |
09/1/2023 08:19 | 2.5 gone!!! | billthebank | |
09/1/2023 08:16 | Absolutebloodlyluutt | the chairman elect | |
09/1/2023 08:15 | Real deal!!!! | billthebank | |
09/1/2023 08:11 | Huge rise here.....either the real deal or a fundraiser pump. I know what my thoughts are....... | badger60 | |
09/1/2023 07:30 | Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "We are pleased now to be announcing further exciting developments in our CBR platform. CBR is a ground-breaking new approach to treat existing and emerging viral infections as well as potentially becoming an effective new form of cancer treatment. On the viral front, its potential ability to treat a very wide range of viruses give it the potential to revolutionise the treatment of viral diseases and even to become the means of counteracting biological warfare." | the chairman elect | |
09/1/2023 07:30 | Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "We are pleased now to be announcing further exciting developments in our CBR platform. CBR is a ground-breaking new approach to treat existing and emerging viral infections as well as potentially becoming an effective new form of cancer treatment. On the viral front, its potential ability to treat a very wide range of viruses give it the potential to revolutionise the treatment of viral diseases and even to become the means of counteracting biological warfare." | the chairman elect | |
09/1/2023 07:23 | Wow....not a scientist, but that reads very well to me. | molatovkid | |
09/1/2023 07:20 | Very welcome RNS | wapper | |
09/1/2023 07:15 | Good day ahead | richer133 | |
08/1/2023 16:01 | If you look at the recent trades then it's all been pm stuff ,6p target may well be hit by the pm boys. | jotoha2 | |
08/1/2023 05:41 | ...oh yeah .....as per usual the LSE Muppets start talking share price telephone numbers on a spike rise accompanied by MadVlad verbals. FUNDRAISER!!!!!..... | badger60 | |
07/1/2023 01:48 | ....oh dear...it's already dropped back to 1.85p. ....... | badger60 | |
07/1/2023 01:42 | Wrong. I sold out of Deltic a few weeks ago (you can see my posts on the Delt BB). What I have bought in the meantime is some PRD.....likewise look at the PRD BB. Hemo up at 2.05p ....good luck and sell up before it drops back. | badger60 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions